NCT06208124 2025-05-28
A Study of IMM-6-415 in RAS/RAF Mutant Solid Tumors
Immuneering Corporation
Phase 1/2 Completed
Clinical Trials
5 trialsNCT01748448 2025-02-17
ViDMe
Universitaire Ziekenhuizen KU Leuven
Phase 3 Completed
NCT02308553 2020-10-14
NIPAWILMA
University Hospital, Essen
Phase 1/2 Completed
NCT03541148 2018-05-30
Evaluation of Oncoxin-Viusid® in Cutaneous Melanoma
Catalysis SL
Phase 2 Completed
NCT00816374 2014-05-16
Tailored Intervention for Melanoma Patient's Families
Fox Chase Cancer Center
Phase NA Completed